Patents by Inventor Isao Fujita

Isao Fujita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STEVIOL GLYCOSIDE
    Publication number: 20210037864
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Application
    Filed: October 28, 2020
    Publication date: February 11, 2021
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • TURBOMACHINERY
    Publication number: 20210017875
    Abstract: A turbomachinery according to an embodiment includes an impeller including at least one blade, and a casing for housing the impeller rotatably. A size of a gap between a tip of the blade and an inner surface of the casing during a stop of the impeller is formed non-uniformly over a circumferential direction of the impeller.
    Type: Application
    Filed: December 21, 2018
    Publication date: January 21, 2021
    Applicant: MITSUBISHI HEAVY INDUSTRIES ENGINE & TURBOCHARGER, LTD.
    Inventors: Isao TOMITA, Reiko TAKASHIMA, Yutaka FUJITA
  • Steviol glycoside
    Patent number: 10849346
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: December 1, 2020
    Assignee: MORITA KAGAKU KOGYO CO., LTD.
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • IMPELLER FOR CENTRIFUGAL COMPRESSOR, CENTRIFUGAL COMPRESSOR, AND TURBOCHARGER
    Publication number: 20200355198
    Abstract: An impeller for a centrifugal compressor includes a plurality of blades arranged around a hub, and on a trailing edge of the blade, a blade angle at a first position on a shroud side from a center position in a span direction of the blade is larger than a blade angle at a second position on a hub side from the center position.
    Type: Application
    Filed: February 7, 2020
    Publication date: November 12, 2020
    Inventors: Hironori HONDA, Kenichiro IWAKIRI, Isao TOMITA, Yutaka FUJITA
  • Fused pyrimidine compound or salt thereof
    Patent number: 10807986
    Abstract: The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I): wherein A, R2, and X are as defined in the specification; or a salt thereof.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: October 20, 2020
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Isao Miyazaki, Tadashi Shimamura, Masanori Kato, Hidenori Fujita, Satoru Iguchi
  • Fused pyrimidine compound or salt thereof
    Patent number: 10787457
    Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: September 29, 2020
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Isao Miyazaki, Tadashi Shimamura, Masanori Kato, Hidenori Fujita
  • NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF
    Publication number: 20200270253
    Abstract: The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I): wherein A, R2, and X are as defined in the specification; or a salt thereof.
    Type: Application
    Filed: May 13, 2020
    Publication date: August 27, 2020
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Isao MIYAZAKI, Tadashi SHIMAMURA, Masanori KATO, Hidenori FUJITA, Satoru IGUCHI
  • FUSED PYRIMIDINE COMPOUND OR SALT THEREOF
    Publication number: 20200270261
    Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.
    Type: Application
    Filed: April 22, 2020
    Publication date: August 27, 2020
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Isao MIYAZAKI, Tadashi SHIMAMURA, Masanori KATO, Hidenori FUJITA
  • FUSED PYRIMIDINE COMPOUND OR SALT THEREOF
    Publication number: 20200270260
    Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.
    Type: Application
    Filed: April 22, 2020
    Publication date: August 27, 2020
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Isao MIYAZAKI, Tadashi SHIMAMURA, Masanori KATO, Hidenori FUJITA
  • STEVIOL GLYCOSIDE
    Publication number: 20190357581
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Application
    Filed: August 12, 2019
    Publication date: November 28, 2019
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF
    Publication number: 20190330214
    Abstract: The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I): wherein A, R2, and X are as defined in the specification; or a salt thereof.
    Type: Application
    Filed: November 1, 2018
    Publication date: October 31, 2019
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Isao MIYAZAKI, Tadashi SHIMAMURA, Masanori KATO, Hidenori FUJITA, Satoru IGUCHI
  • Steviol glycoside
    Patent number: 10420360
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the Stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: September 24, 2019
    Assignee: MORITA KAGAKU KOGYO CO., LTD.
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • STEVIOL GLYCOSIDE
    Publication number: 20180077959
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Application
    Filed: November 30, 2017
    Publication date: March 22, 2018
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • Steviol glycoside
    Patent number: 9848632
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: December 26, 2017
    Assignee: MORITA KAGAKU KOGYO CO., LTD.
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • DISK APPARATUS AND CONTROL METHOD
    Publication number: 20160170891
    Abstract: According to one embodiment, there is provided a disk apparatus including a disk medium, a nonvolatile memory, and a controller. In the nonvolatile memory, data to be recorded to the disk medium is written. The controller is configured to perform, according to amount of free space of the nonvolatile memory, write process of the data in the nonvolatile memory collectively, or in multiple times with dividing the write process.
    Type: Application
    Filed: March 4, 2015
    Publication date: June 16, 2016
    Inventors: Michio Yamamoto, Isao Fujita, Takumi Kakuya, Masami Tashiro, Yuka Kuwano, Takato Kuji, Katsushi Ohta, Seiji Toda
  • STEVIOL GLYCOSIDE
    Publication number: 20160058050
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Application
    Filed: November 10, 2015
    Publication date: March 3, 2016
    Inventors: Toyoshige MORITA, Isao FUJITA, Fumito MATSUURA, Masaya OTA
  • Steviol glycoside
    Patent number: 9215889
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: December 22, 2015
    Assignee: MORITA KAGAKU KOGYO CO., LTD.
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota
  • Read/write apparatus and read/write method
    Patent number: 8879181
    Abstract: According to one embodiment, a read/write apparatus includes a receiver and a refresh module. The receiver receives a write command requesting a write to a magnetic disk. The refresh module refreshes, when a first area of the magnetic disk includes a second area corresponding to the write command, data written in a third area, the third area being an area obtained by excluding the second area from the first area.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: November 4, 2014
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Seiji Toda, Michio Yamamoto, Masakazu Kitahara, Masataka Shitara, Takumi Kakuya, Kiyotaka Sasaki, Isao Fujita, Satoru Adachi, Kenji Inoue, Nobuhiro Sugawara, Hironori Kanno
  • NEW STEVIOL GLYCOSIDE
    Publication number: 20140187761
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 3, 2014
    Applicant: MORITA KAGAKU KOGYO CO., LTD.
    Inventors: Toyoshige MORITA, Isao FUJITA, Fumito MATSUURA, Masaya OTA
  • Steviol glycoside
    Patent number: 8703225
    Abstract: Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: April 22, 2014
    Assignee: Morita Kagaku Kogyo Co., Ltd.
    Inventors: Toyoshige Morita, Isao Fujita, Fumito Matsuura, Masaya Ota